{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:42:29Z","timestamp":1648597349363},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00393-012-1082-9","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T08:02:57Z","timestamp":1364976177000},"page":"242-254","source":"Crossref","is-referenced-by-count":1,"title":["Metabolische und mitochondriale Myopathien"],"prefix":"10.1007","volume":"72","author":[{"given":"M.","family":"Vorgerd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"1082_CR1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/adc.2008.146548","volume":"79","author":"Andersen","year":"2008","unstructured":"Andersen ST, Vissing J (2008) Carbohydrate- and protein-rich diets in McArdle disease: effect on exercise capacity. J Neurol Neurosurg Psychiatry 79:1359\u20131363","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1082_CR2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archneur.65.6.786","volume":"65","author":"Andersen","year":"2008","unstructured":"Andersen ST, Haller RG, Vissing J (2008) Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch Neurol 65:786\u2013789","journal-title":"Arch Neurol"},{"key":"1082_CR3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0028-1109800","volume":"226","author":"Bau","year":"2009","unstructured":"Bau V, Deschauer M, Zierz S (2009) Chronisch progressive externe Ophthalmoplegie \u2013 Symptom oder Syndrom? Klin Monatsbl Augenheilkd 226:822\u2013828","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1082_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1056\/NEJMc0806334","volume":"360","author":"Bonnefont","year":"2009","unstructured":"Bonnefont JP, Bastin J, Behin A, Djouadi F (2009) Bezafibrate for an inborn mitochondrial beta-oxidation defect. N Engl J Med 360:838\u2013840","journal-title":"N Engl J Med"},{"key":"1082_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.20565","volume":"58","author":"Busch","year":"2005","unstructured":"Busch V, Gempel K, Hack A et al (2005) Treatment of glycogenosis type V with ketogenic diet. Ann Neurol 58:341","journal-title":"Ann Neurol"},{"key":"1082_CR6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/archneur.58.11.1885","volume":"58","author":"Deschauer","year":"2001","unstructured":"Deschauer M, M\u00fcller T, Wieser T et al (2001) Hearing impairment is common in various phenotypes of the mitochondrial DNA A3243G mutation. Arch Neurol 58:1885\u20131888","journal-title":"Arch Neurol"},{"key":"1082_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","volume":"62","author":"Deschauer","year":"2005","unstructured":"Deschauer M, Wieser T, Zierz S (2005) Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 62:37\u201341","journal-title":"Arch Neurol"},{"key":"1082_CR8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.63.6.902","volume":"63","author":"Deschauer","year":"2006","unstructured":"Deschauer M, Swalwell H, Strauss M et al (2006) Novel mitochondrial tRNAPhe gene mutation associated with late-onset neuromuscular disease. Arch Neurol 63:902\u2013905","journal-title":"Arch Neurol"},{"key":"1082_CR9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00415-006-0447-x","volume":"254","author":"Deschauer","year":"2007","unstructured":"Deschauer M, Morgenroth A, Joshi PR et al (2007) Analysis of spectrum and frequencies of mutations in McArdle disease: identification of 13 novel mutations. J Neurol 254:797\u2013802","journal-title":"J Neurol"},{"key":"1082_CR10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mus.1103","volume":"24","author":"DiMauro","year":"2001","unstructured":"DiMauro S, Lamperti C (2001) Muscle glycogenoses. Muscle Nerve 24:984\u2013999","journal-title":"Muscle Nerve"},{"key":"1082_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1015109127986","volume":"25","author":"Gempel","year":"2002","unstructured":"Gempel K, Kiechl S, Hofmann S et al (2002) Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis 25:17\u201327","journal-title":"J Inherit Metab Dis"},{"key":"1082_CR12","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","volume":"130","author":"Gempel","year":"2007","unstructured":"Gempel K, Topaloglu H, Talim B et al (2007) The myopathic form of coenzymeQ10 deficiency is caused by mutations in the electron-transferringflavoproteindehydrogenase (ETFDH) gene. Brain 130:2037\u20132044","journal-title":"Brain"},{"key":"1082_CR13","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ana.20881","volume":"59","author":"Haller","year":"2006","unstructured":"Haller RG, Wyrick MA, Tailvassalo T, Vissing J (2006) Aerobic conditioning: an effective therapy in McArdle\u2019s disease. Ann Neurol 59:922\u2013928","journal-title":"Ann Neurol"},{"key":"1082_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00415-006-0987-0","volume":"253","author":"Hanisch","year":"2006","unstructured":"Hanisch F, M\u00fcller T, Muser A et al (2006) Lactate increase and oxygen desaturation in mitochondrial disorders \u2013 evaluation of two diagnostic screening protocols. J Neurol 253:417\u2013423","journal-title":"J Neurol"},{"key":"1082_CR15","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/brain\/awl088","volume":"129","author":"Horvath","year":"2006","unstructured":"Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674\u20131684","journal-title":"Brain"},{"key":"1082_CR16","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1093\/brain\/awl149","volume":"129","author":"Jeppesen","year":"2006","unstructured":"Jeppesen TD, Schwartz M, Olsen DB et al (2006) Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 129:3402\u20133412","journal-title":"Brain"},{"key":"1082_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10545-008-0820-2","volume":"31","author":"Joshi","year":"2008","unstructured":"Joshi PR, Gl\u00e4ser D, Schmidt S et al (2008) Molecular genetic characterization of German patients with late-onset glycogen storage disease type II. J Inherit Metab Dis 31(Suppl 2):261\u2013265","journal-title":"J Inherit Metab Dis"},{"key":"1082_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.10263","volume":"52","author":"Kazemi-Esfarjani","year":"2002","unstructured":"Kazemi-Esfarjani P, Skomorowska E, Jensen TD et al (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neurol 52:153\u2013159","journal-title":"Ann Neurol"},{"key":"1082_CR19","first-page":"89","volume":"149","author":"Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M et al (2007) Recombinant human acid alpha-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 149:89\u201397","journal-title":"Neurology"},{"key":"1082_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","volume":"142C","author":"Longo","year":"2006","unstructured":"Longo N, Di San Filippo CA, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet Part C Semin Med Genet 142C:77\u201385","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"1082_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mus.21167","volume":"39","author":"Ohkuma","year":"2009","unstructured":"Ohkuma A, Noguchi S, Sugie H et al (2009) Clinical and genetic analysis of lipid storage myopathies. Muscle Nerve 39:333\u2013342","journal-title":"Muscle Nerve"},{"key":"1082_CR22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","volume":"130","author":"Olsen","year":"2007","unstructured":"Olsen RK, Olpin SE, Andresen BS et al (2007) ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 130:2045\u20132054","journal-title":"Brain"},{"key":"1082_CR23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0960-8966(98)00004-2","volume":"8","author":"Phoenix","year":"1998","unstructured":"Phoenix J, Hopkins P, Bartram C et al (1998) Effect of vitamin B6 supplementation in McArdle\u2019s disease: a strategic case study. Neuromuscul Disord 8:210\u2013212","journal-title":"Neuromuscul Disord"},{"key":"1082_CR24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI0215311","volume":"110","author":"Roe","year":"2002","unstructured":"Roe CR, Sweetman L, Roe DS et al (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110:259\u2013269","journal-title":"J Clin Invest"},{"key":"1082_CR25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/01.wnl.0000318283.42961.e9","volume":"71","author":"Roe","year":"2008","unstructured":"Roe CR, Yang BZ, Brunengraber H et al (2008) Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 71:260\u2013264","journal-title":"Neurology"},{"key":"1082_CR26","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/brain\/awl282","volume":"29","author":"Taivassalo","year":"2006","unstructured":"Taivassalo T, Gardner JL, Taylor RW et al (2006) Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 29:3391\u20133401","journal-title":"Brain"},{"key":"1082_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nmd.2003.12.004","volume":"14","author":"Taylor","year":"2004","unstructured":"Taylor RW, Schaefer AM, Barrin MJ et al (2004) The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 14:237\u2013245","journal-title":"Neuromuscul Disord"},{"key":"1082_CR28","first-page":"456","volume":"107","author":"Van","year":"2010","unstructured":"Van der Ploeg AT, Barohn R, Carlson L et al (2010) Open-label extension study following the Late-onset Treatment Study (LOTS) of alglucosidase alfa. Mol Genet Metab 107:456\u2013461","journal-title":"Mol Genet Metab"},{"key":"1082_CR29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archneur.57.7.956","volume":"57","author":"Vorgerd","year":"2000","unstructured":"Vorgerd M, Grehl T, Jager M et al (2000) Creatine therapy in myophosphorylase deficiency (McArdle\u2019s disease). A placebo controlled crossover trial. Arch Neurol 57:956\u2013963","journal-title":"Arch Neurol"},{"key":"1082_CR30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.59.1.97","volume":"59","author":"Vorgerd","year":"2002","unstructured":"Vorgerd M, Zange J, Kley R et al (2002) Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle\u2019s disease: double-blind, placebo-controlled crossover trial. Arch Neurol 59:97\u2013101","journal-title":"Arch Neurol"},{"key":"1082_CR31","doi-asserted-by":"crossref","unstructured":"Vorgerd M, Deschauer M (2011) Treatment and management of hereditary metabolic myopathies. In: Bertorini TE (Hrsg) Neuromuscular disorders. Treatment and management. Elsevier, Philadelphia, S\u00a0409\u2013429","DOI":"10.1016\/B978-1-4377-0372-6.00022-0"},{"key":"1082_CR32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0028-1109800","volume":"226","author":"Bau","year":"2009","unstructured":"Bau V, Deschauer M, Zierz S (2009) Chronisch progressive externe Ophthalmoplegie \u2013 Symptom oder Syndrom? Klin Monatsbl Augenheilkd 226:822\u2013828","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1082_CR33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2003-38712","volume":"29","author":"Deschauer","year":"2003","unstructured":"Deschauer M (2003) Mitochondriale Enzephalomyopathien. Psychoneuro 29:108\u2013112","journal-title":"Psychoneuro"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-1082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-012-1082-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-1082-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T18:04:02Z","timestamp":1562868242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-012-1082-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s00393-012-1082-9","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}